These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3346401)

  • 21. Efficacy of transdermal scopolamine against seasickness: a 3-day study at sea.
    Attias J; Gordon C; Ribak J; Binah O; Rolnick A
    Aviat Space Environ Med; 1987 Jan; 58(1):60-2. PubMed ID: 3814034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study utilizing transdermal scopolamine in detrusor instability.
    Cornella JL; Bent AE; Ostergard DR; Horbach NS
    Urology; 1990 Jan; 35(1):96-7. PubMed ID: 2296827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scopolamine patch can be confusing to the patient and anesthesiologist: a case report.
    Elias MA; Abouleish E
    Anesthesiology; 1997 Mar; 86(3):743-4. PubMed ID: 9066342
    [No Abstract]   [Full Text] [Related]  

  • 24. Transdermal therapeutic systems and rate controlled drug delivery.
    Yum SI
    Med Prog Technol; 1989; 15(1-2):47-52. PubMed ID: 2530425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contact dermatitis to transdermal estradiol system.
    McBurney EI; Noel SB; Collins JH
    J Am Acad Dermatol; 1989 Mar; 20(3):508-10. PubMed ID: 2918119
    [No Abstract]   [Full Text] [Related]  

  • 26. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
    Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM
    Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review.
    Kranke P; Morin AM; Roewer N; Wulf H; Eberhart LH
    Anesth Analg; 2002 Jul; 95(1):133-43, table of contents. PubMed ID: 12088957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scopolamine patch-induced unilateral mydriasis.
    Thiele EA; Riviello JJ
    Pediatrics; 1995 Sep; 96(3 Pt 1):525. PubMed ID: 7651791
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety of double-dose transdermal scopolamine.
    Bar R; Gil A; Tal D
    Pharmacotherapy; 2009 Sep; 29(9):1082-8. PubMed ID: 19698013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Scopolamine plaster caused hallucination. Toxic psychosis in a 10-year-old boy caused by an agent against motion sickness].
    Björk M; Wettergren B
    Lakartidningen; 1995 Feb; 92(7):638. PubMed ID: 7861858
    [No Abstract]   [Full Text] [Related]  

  • 31. Scopolamine: new preparations. Reference treatment for death rattle.
    Prescrire Int; 2001 Aug; 10(54):99-101. PubMed ID: 11718188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of transcutaneous scopolamine and depth on diver performance.
    Williams TH; Wilkinson AR; Davis FM; Frampton CM
    Undersea Biomed Res; 1988 Mar; 15(2):89-98. PubMed ID: 3363755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cruise ship anisocoria.
    Riddick FA; Jordan JD
    Ann Intern Med; 1992 Jul; 117(1):95. PubMed ID: 1596061
    [No Abstract]   [Full Text] [Related]  

  • 34. [A draftee got a CNS disorder after treatment with scopolamine plaster].
    Olevik P
    Lakartidningen; 1987 Apr; 84(17):1463. PubMed ID: 3586788
    [No Abstract]   [Full Text] [Related]  

  • 35. Cycloplegia from transdermal scopolamine.
    Vincent FM; Vincent T
    South Med J; 1985 Dec; 78(12):1527-8. PubMed ID: 4071194
    [No Abstract]   [Full Text] [Related]  

  • 36. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
    Corazza M; Mantovani L; Montanari A; Virgili A
    J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine.
    Patel PN; Ezzo DC
    Am J Health Syst Pharm; 2009 Nov; 66(22):2024-6. PubMed ID: 19890085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy.
    Bailey PL; Streisand JB; Pace NL; Bubbers SJ; East KA; Mulder S; Stanley TH
    Anesthesiology; 1990 Jun; 72(6):977-80. PubMed ID: 2140929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accidental mydriasis from scopolamine patches.
    Rosen NB
    J Am Optom Assoc; 1986 Jul; 57(7):541-2. PubMed ID: 3745760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal scopolamine in the prevention of motion sickness at sea.
    Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G
    Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.